Wedbush Fund Advisers, LLC

Position in ABBV — AbbVie Inc.

CIK 2070852 Pasadena, CA

Position in ABBV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$22,647

New position

Shares Held

90

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#4,109

of 4,153 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Wedbush Fund Advisers, LLC holds $78,452 across 5 Drug Manufacturers - General names. ABBV ranks #1 (28.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	90	$22,647
2	AMGN	Amgen Inc	49	$17,743
3	LLY	ELI LILLY & Co	12	$14,393
4	GILD	Gilead Sciences, Inc.	95	$12,002
5	BIIB	Biogen Inc.	54	$11,667

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$22,647	90	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.